Razavi H. The cost-effectiveness of hepatitis C virus elimination in low- and middle-income countries. J Viral Hepat. 2021 Feb;28(2):445. doi: 10.1111/jvh.13442. Epub 2020 Dec 1.…
Vince, A., Dugan, E., Nemeth-Blažić, T., Filipec, T., Hrstic, I., Lukšić, B., Nonkovic, D., Reic, T., Coleman, S., Razavi, H., Blach, S. (2020). Strategies to…
Polaris Observatory Collaborators. The case for simplifying and using absolute targets for viral hepatitis elimination goals. J Viral Hepat 2021;28:12–19. Summary The 69th World Health…
Dunn R, Musabaev E, Razavi H, Sadirova S, Bakieva S, Razavi-Shearer K, Brigida K, Kamili S, Averhoff F, Nasrullah M. Progress Toward Hepatitis B and…
Blach S, Kondili LA, Aghemo A, Cai Z, Dugan E, Estes C, Gamkrelidze I, Ma S, Pawlotsky JM, Razavi-Shearer D, Razavi H, Waked I, Zeuzem…
Palayew A, Stumo SR, Cooke GS, Hutchinson SJ, Jauffret-Roustide M, Maticic M, Harris M, Metwally AM, Razavi H, Lazarus JV; Hep-CORE Study Group. The Hep-CORE…
Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
Palayew A, Razavi H, Hutchinson SJ, Cooke GS, Lazarus JV. Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B…
Kondili LA, Blach S, Razavi H, Craxì A. Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road…
Razavi H. Global Epidemiology of Viral Hepatitis. Gastroenterol Clin North Am. 2020 Jun;49(2):179-189. doi: 10.1016/j.gtc.2020.01.001. PMID: 32389357. Summary Viral hepatitis (hepatitis A, B, C, D,…
Binka M, Janjua NZ, Grebely J, Estes C, Schanzer D, Kwon JA, Shoukry NH, Kwong JC, Razavi H, Feld JJ, Krajden M. Assessment of Treatment…